Skip to main content

Advertisement

Log in

Islet Versus Pancreas Transplantation in Type 1 Diabetes: Competitive or Complementary?

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Whole organ pancreas and pancreatic islet transplantation are currently the only forms of clinically available β-cell replacement. Both therapeutic options can provide good glycemic control and prevention or stabilization of diabetic complications, but at the price of permanent immunosuppression. Therefore, the indication for transplantation of type 1 diabetes patients must be balanced carefully and should be restricted to a subgroup of patients with extreme lability of metabolic control and frequent hypoglycemia despite optimal medical therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Steffes MW, Sibley S, Jackson M, Thomas W: Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003, 26:832–836.

    Article  PubMed  Google Scholar 

  2. Kelly WD, Lillehei RC, Merkel FK, et al.: Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967, 61:827–837.

    CAS  PubMed  Google Scholar 

  3. Gruessner AC, Sutherland DE: Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005, 19:433–455.

    Article  PubMed  Google Scholar 

  4. Venstrom JM, McBride MA, Rother KI, et al.: Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003, 290:2817–2823.

    Article  CAS  PubMed  Google Scholar 

  5. Ballinger WF, Lacy PE: Transplantation of intact pancreatic islets in rats. Surgery 1972, 72:175–186.

    CAS  PubMed  Google Scholar 

  6. Shapiro AM, Lakey JR, Ryan EA, et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230–238.

    Article  CAS  PubMed  Google Scholar 

  7. Ojo AO, Meier-Kriesche HU, Hanson JA, et al.: The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001, 71:82–90.

    Article  CAS  PubMed  Google Scholar 

  8. Robertson P, Davis C, Larsen J, et al.: Pancreas transplantation in type 1 diabetes. Diabetes Care 2004, 27(Suppl 1):S105.

    PubMed  Google Scholar 

  9. • Sollinger HW, Odorico JS, Becker YT, et al.: One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 2009, Aug 27 [Epub ahead of print]. This paper shows the largest cohort of SPK transplants at a single center ever with the longest follow-up period of more than 20 years. This is an impressive report by Dr. Sollinger, one of the true pioneers in pancreas transplantation, sharing his tremendous experience in the pancreas transplant field.

  10. Fioretto P, Steffes MW, Sutherland DE, et al.: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998, 339:69–75.

    Article  CAS  PubMed  Google Scholar 

  11. Coppelli A, Giannarelli R, Vistoli F, et al.: The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care 2005, 28:1366–1370.

    Article  PubMed  Google Scholar 

  12. Giannarelli R, Coppelli A, Sartini M, et al.: Effects of pancreas-kidney transplantation on diabetic retinopathy. Transpl Int 2005, 18:619–622.

    Article  PubMed  Google Scholar 

  13. Koznarova R, Saudek F, Sosna T, et al.: Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000, 9:903–908.

    CAS  PubMed  Google Scholar 

  14. Gaber AO, Oxley D, Karas J, et al.: Changes in gastric emptying in recipients of successful combined pancreas-kidney transplants. Dig Dis 1991, 9:437–443.

    Article  CAS  PubMed  Google Scholar 

  15. Hathaway DK, Abell T, Cardoso S, et al.: Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. Transplantation 1994, 57:816–822.

    Article  CAS  PubMed  Google Scholar 

  16. Perkins BA, Bril V: Diagnosis and management of diabetic neuropathy. Curr Diab Rep 2002, 2:495–500.

    Article  PubMed  Google Scholar 

  17. Morath C, Zeier M, Dohler B, et al.: Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. J Am Soc Nephrol 2008, 19:1557–1563.

    Article  PubMed  Google Scholar 

  18. Coppelli A, Giannarelli R, Mariotti R, et al.: Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. Transplantation 2003, 76:974–976.

    Article  PubMed  Google Scholar 

  19. Fiorina P, La Rocca E, Astorri E, et al: Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients. Diabetes Care 2000, 23:1804–1810.

    Article  CAS  PubMed  Google Scholar 

  20. Fiorina P, La Rocca E, Venturini M, et al.: Effects of kidney-pancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 2001, 50:496–501.

    Article  CAS  PubMed  Google Scholar 

  21. Jukema JW, Smets YF, van der Pijl JW, et al.: Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 2002, 25:906–911.

    Article  PubMed  Google Scholar 

  22. Larsen JL, Colling CW, Ratanasuwan T, et al.: Pancreas transplantation improves vascular disease in patients with type 1 diabetes. Diabetes Care 2004, 27:1706–1711.

    Article  PubMed  Google Scholar 

  23. Larsen JL, Ratanasuwan T, Burkman T, et al.: Carotid intima media thickness decreases after pancreas transplantation. Transplantation 2002, 73:936–940.

    Article  PubMed  Google Scholar 

  24. Luan FL, Miles CD, Cibrik DM, Ojo AO: Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus. Transplantation 2007, 84:541–544.

    Article  PubMed  Google Scholar 

  25. Ryan EA, Paty BW, Senior PA, et al.: Five-year follow-up after clinical islet transplantation. Diabetes 2005, 54:2060–2069.

    Article  CAS  PubMed  Google Scholar 

  26. Leitao CB, Tharavanij T, Cure P, et al.: Restoration of hypoglycemia awareness after islet transplantation. Diabetes Care 2008, 31:2113–2115.

    Article  PubMed  Google Scholar 

  27. Rickels MR, Schutta MH, Markmann JF, et al.: {beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes 2005, 54:100–106.

    Article  CAS  PubMed  Google Scholar 

  28. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group [no authors listed]. N Engl J Med 1993, 329:977–986.

  29. • Gerstein HC, Miller ME, Byington RP, et al.: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545–2559. This is a highly controversial large multicenter study (ACCORD) that investigated the effect of intensive insulin therapy on cardiovascular events in type 2 diabetes patients. The initial conclusion of increased risk by rigorous glucose lowering provoked the whole diabetes world.

    Article  CAS  PubMed  Google Scholar 

  30. Fiorina P, Gremizzi C, Maffi P, et al.: Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care 2005, 28:1358–1365.

    Article  PubMed  Google Scholar 

  31. Fiorina P, Folli F, Zerbini G, et al.: Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol 2003, 14:2150–2158.

    Article  PubMed  Google Scholar 

  32. Lee TC, Barshes NR, O’Mahony CA, et al.: The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy. Transplant Proc 2005, 37:2263–2265.

    Article  CAS  PubMed  Google Scholar 

  33. de Mattos AM, Olyaei AJ, Bennett WM: Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 2000, 35:333–346.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barbara Ludwig.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ludwig, B., Ludwig, S., Steffen, A. et al. Islet Versus Pancreas Transplantation in Type 1 Diabetes: Competitive or Complementary?. Curr Diab Rep 10, 506–511 (2010). https://doi.org/10.1007/s11892-010-0146-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-010-0146-y

Keywords

Navigation